Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies

NCT06287411 is registered in ClinicalTrials.gov with Xiao Chen as lead sponsor.

NCT NCT06287411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06287411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies
Lead sponsor
Xiao Chen
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2023
Completion date
December 31, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic malignancies